Page 79 - Tata-Trusts-Annual-Report-2022-23
P. 79
municipal/administrative agencies, research institutes CARNEGIE INDIA
and universities at both the national and international
levels, industries and start-ups, hospitals, NGOs and Founded in 2016, Carnegie India, based in New Delhi, is
patient support groups across the city and beyond. TIGS part of a robust global network that includes over 150
has been a key partner in multiple grants, including from scholars in Asia, Beirut, Brussels, and Washington. Led by
the Rockefeller Foundation supporting multi-centre Indian experts with decades of international and domestic
programme for setting up pathogen monitoring systems policy experience, Carnegie India engages with
(Alliance for Pathogen Surveillance Innovations-India), governments, policymakers, academics, students,
as well as competitive research grants from government industries, practitioners, and civil society to provide
agencies such as the ICMR, SERB-DST, DBT, etc. for independent, insightful, and fresh analyses of India’s
translational science in the areas of diagnostics and pressing challenges and the rising role of India in the
therapeutics in healthcare. world, in ways that are at once topical and panoptic.
The Trusts have been supporting Carnegie India through
• Outreach events and societal engagements: About 10
an institutional grant to grow its research programme and
webinars and public lectures were hosted by TIGS along
to conduct national summits and events, in order to inform
with the initiation of a new TIGS podcast channel for
public policy.
science communication, leading to an engagement with
over 14,000 people on various topics such as wastewater
surveillance, air surveillance of COVID-19, antimicrobial KEY ACHIEVEMENTS
resistance (AMR) and infectious disease monitoring, rare
genetic disorders screening and diagnostics, mRNA Research:
therapeutics, pest management and crop improvement
technologies. Along with the Organization for Rare • India–U.S. Initiative on Critical and Emerging
Diseases, India (ORDI), TIGS also organised the first Technologies (iCET): The iCET focuses on fostering
National Rare Diseases Research Summit (REDRESS – deeper technology ties between India and the United
2022) in November 2022, which served as an indigenous States and aims to bring together stakeholders from
and recurrent platform to bring together all rare disease di erent domains to discuss areas of technology
researchers and stakeholders working for the Indian cooperation. Carnegie India has been working on
Rare Disease population, with an aim of indigenization building the agenda for the iCET. In addition to research
and acceleration of diagnostics, therapeutics, and and publications, Carnegie has conducted two
management, through potential cross-disciplinary high-level private discussions - in New Delhi and
collaborations. Washington D.C. - with key stakeholders from
government, industry, academia, and think tanks.
• Semiconductors: Carnegie India continues to
explore the area of semiconductor supply chains, which
is becoming increasingly diversified. Regarding
semiconductors, the focus at Carnegie India is two-fold:
(a) discussion of how recent U.S. export control
measures have unleashed second-order e ects that
have created uncertainty for semiconductor companies
ANNUAL REPORT 2022-23 72
